Evotec AG

FRA:EVT ISIN:DE0005664809

Evotec AG (ETR:EVT) is a drug discovery and development company focused on providing integrated and drug discovery services and alliances to the pharmaceutical and biotechnology industry. In addition the Company has a small number of its own drug candidates at various stages of development either partnered or available for partnering. Through its Discovery Alliance Business, Evotec provides and integrated solutions to the pharmaceutical and biotechnology industry from target to clinical development through a range of capabilities and capacities. 
 

News

Evotec AG (FRA:EVT) Evotec Reports Strong Third Quarter 2008 And Improves Full-Year Guidance

🕔11/14/2008 4:47:00 PM 1365

Evotec AG (FRA:EVT) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Read Full Article

Evotec AG (FRA:EVT) Evotec To Report Third Quarter 2008 Results On November 14, 2008

🕔11/8/2008 12:17:00 AM 1404

Hamburg, Germany - Evotec AG (Frankfurt Stock Exchange: EVT, NASDAQ: EVTC) will report its financial results for the third quarter of 2008 on Friday, November 14, 2008.

Read Full Article

Evotec AG (OJ:EVT) Evotec Earns Two Milestone Payments From Boehringer Ingelheim

🕔10/31/2008 10:48:46 AM 1253

Evotec AG (OJ:EVT) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Read Full Article

Evotec AG (OJ:EVT) Evotec Reports Phase I Safety Data From Tyramine Interaction Study with EVT 302

🕔10/27/2008 9:09:00 PM 1146

Evotec AG (OJ:EVT) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Read Full Article

Evotec AG (OJ:EVT) Evotec Announces Phase I Initiation With P2X7 Antagonist

🕔10/9/2008 4:53:00 PM 1215

Evotec AG (OJ:EVT) Corporate news announcement processed and transmitted by Hugin ASA. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Read Full Article

Evotec AG (OJ:EVT) Evotec To Present At The UBS Global Life Sciences Conference In New York

🕔9/18/2008 11:01:00 PM 1295

Evotec AG (OJ:EVT) Corporate news announcement processed and transmitted by Hugin ASA. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Read Full Article

Evotec AG (OJ:EVT) Evotec Participates In The Sale Of Direvo Biotech To Bayer Healthcare

🕔9/16/2008 8:53:00 PM 1017

Evotec AG (OJ:EVT) Corporate news announcement processed and transmitted by Hugin ASA. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Read Full Article

Evotec AG (OJ:EVT) Evotec Reports Start Of Phase II Proof-of-Concept Quit Rate Study with EVT 302 And Results Of Craving Study

🕔9/11/2008 4:57:00 PM 1204

Evotec AG (OJ:EVT) Corporate news announcement processed and transmitted by Hugin ASA. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Read Full Article

Evotec AG; Evotec And Boehringer Ingelheim Achieve Milestone In Joint Discovery Collaboration

🕔9/2/2008 5:43:00 PM 1015

Corporate news announcement processed and transmitted by Hugin ASA. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------

Read Full Article
###

1,918 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 8) (Last 30 Days: 28) (Since Published: 1918) 

Company Data

    Headquarters
  • Schnackenburgallee 114
    Hamburg, 22525
    Germany
  • Telephone
  • +49-40-560810 
  • Fax
  • +49-40-56081222 
  • Principal Sector
  • Drugs & OTC 
  • Principal Industry
  • Biotechnology 
  • Homepage
  • www.evotec.com